SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,000 | -62.5% | 111 | -62.1% | 0.00% | – |
Q3 2021 | $8,000 | -100.0% | 293 | -99.9% | 0.00% | -100.0% |
Q2 2021 | $16,080,000 | +92.7% | 522,260 | +63.9% | 0.10% | +76.3% |
Q1 2021 | $8,344,000 | -74.5% | 318,706 | -75.5% | 0.06% | -80.5% |
Q4 2020 | $32,759,000 | +59.8% | 1,302,015 | +32.4% | 0.30% | +17.0% |
Q3 2020 | $20,494,000 | -9.8% | 983,395 | +2.8% | 0.26% | -13.1% |
Q2 2020 | $22,727,000 | +152.0% | 956,924 | +90.9% | 0.30% | +96.1% |
Q1 2020 | $9,020,000 | -26.8% | 501,392 | -3.4% | 0.15% | +10.9% |
Q4 2019 | $12,317,000 | -46.1% | 519,271 | -37.6% | 0.14% | -49.4% |
Q3 2019 | $22,870,000 | +329.2% | 832,247 | +416.7% | 0.27% | +337.1% |
Q2 2019 | $5,329,000 | +177533.3% | 161,057 | +101834.8% | 0.06% | – |
Q2 2015 | $3,000 | – | 158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |